NIPH Clinical Trials Search

Basic Information

Recruitment status
Health condition(s) or Problem(s) studied	seborrheic dermatitis
Date of first enrollment	06/09/2012
Target sample size
Countries of recruitment
Study type	Interventional
Intervention(s)	investigational material(s) Generic name etc : M110101 INN of investigational material : Therapeutic category code : 264 Analgesics, anti-itchings, astrigents and anti-inflammatory agents Dosage and Administration for Investigational material : Proper quantity twice a day control material(s) Generic name etc : M110101 placebo INN of investigational material : Therapeutic category code : --- Other Dosage and Administration for Investigational material : Proper quantity twice a day

Outcome(s)

Primary Outcome	change of total score in skin symptom
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum	>= 20age old
Age maximum	Not applicable
Gender	Both
Include criteria	Patients diagnosed with sebborrheic dermatitis
Exclude criteria